- Home
- QTRX vs MXCT Comparison
QTRX vs MXCT Comparison
Compare QTRX & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- MXCT
- Stock Information
- Founded
- QTRX 2007
- MXCT 1999
- Country
- QTRX United States
- MXCT United States
- Employees
- QTRX N/A
- MXCT N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- QTRX Industrials
- MXCT Health Care
- Exchange
- QTRX Nasdaq
- MXCT Nasdaq
- Market Cap
- QTRX 233.5M
- MXCT 239.2M
- IPO Year
- QTRX 2017
- MXCT 2021
- Fundamental
- Price
- QTRX $6.12
- MXCT $2.06
- Analyst Decision
- QTRX Buy
- MXCT Strong Buy
- Analyst Count
- QTRX 5
- MXCT 1
- Target Price
- QTRX $15.60
- MXCT $9.00
- AVG Volume (30 Days)
- QTRX 763.5K
- MXCT 922.0K
- Earning Date
- QTRX 08-07-2025
- MXCT 08-05-2025
- Dividend Yield
- QTRX N/A
- MXCT N/A
- EPS Growth
- QTRX N/A
- MXCT N/A
- EPS
- QTRX N/A
- MXCT N/A
- Revenue
- QTRX $135,688,000.00
- MXCT $37,675,000.00
- Revenue This Year
- QTRX N/A
- MXCT $8.82
- Revenue Next Year
- QTRX $14.49
- MXCT $21.12
- P/E Ratio
- QTRX N/A
- MXCT N/A
- Revenue Growth
- QTRX 7.71
- MXCT N/A
- 52 Week Low
- QTRX $4.05
- MXCT $2.03
- 52 Week High
- QTRX $16.74
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- QTRX 55.97
- MXCT 39.29
- Support Level
- QTRX $5.98
- MXCT $2.19
- Resistance Level
- QTRX $6.76
- MXCT $2.28
- Average True Range (ATR)
- QTRX 0.52
- MXCT 0.12
- MACD
- QTRX 0.09
- MXCT 0.00
- Stochastic Oscillator
- QTRX 56.46
- MXCT 7.81
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.